Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.65) per share. This is a 71.05 percent decrease over losses of $(0.38) per share from the same period last year.
Micron Tech Has Strong Demand And Competitive Edge For 2024, Deutsche Bank Upgrades To Buy
Deutsche Bank has upgraded Micron Technology Inc (NASDAQ: MU) from Neutral to Buy with a price target of $85 from $65, a ~20% potential upside from current levels.